These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3591264)

  • 1. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
    Jantzen JP; Erdmann K; Kleemann PP
    Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients].
    Mauritz W; Hackl W; Sporn P; Steinbereithner K
    Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
    Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
    Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
    Free CW; Jaimon MP
    N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
    Schuh FT; Maier C
    Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
    Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
    Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
    Ruhland G; Hinkle AJ
    Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
    Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
    Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
    [No Abstract]   [Full Text] [Related]  

  • 15. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
    Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
    J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
    Schleelein LE; Litman RS
    Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse.
    Valverde A; Boyd CJ; Dyson DH; Pascoe PJ
    J Am Vet Med Assoc; 1990 Oct; 197(8):1051-3. PubMed ID: 2243040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sodium dantrolene].
    Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
    Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
    [No Abstract]   [Full Text] [Related]  

  • 20. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.